Biotech News

Perrigo Announces Quarterly Dividend

Perrigo Company PLC (PRGO)Perrigo Company PLCEarnings

DUBLIN , July 30, 2026 / PRNewswire / -- Perrigo Company plc (NYSE: PRGO), a leading provider of consumer self-care products, today announced that its Board of Directors has approved a quarterly dividend of $0.29 per share, or $1.16 per share on an annualized basis. The cash dividend is payable on September 15, 2026, to shareholders of record on August 28, 2026.

About Perrigo

Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.

Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill ® , Mederma ® , Compeed ® , EllaOne ® , and Jungle Formula ® .

For more information, visit www.perrigo.com .

Forward-Looking Statements

This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings , for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025.

Perrigo Contacts

Eric Jacobson, Vice President, Global Investor Relations [email protected]

Nick Gallagher, Associate Director, Global Investor Relations [email protected]

SOURCE Perrigo Company plc

Related news

Perrigo Company PLC

Consumer Self-Care Portfolio Perrigo is a global provider of over-the-counter health and wellness products intended for conditions that consumers can prevent or manage themselves. Its portfolio spans branded and store-brand medicines and self-care products sold through major retail and pharmacy channels. Consumer and Specialty Care...

Recent company news

Stock data

Close
14.27 USD
Market cap
1.45B USD
Exchange
NYSE
Sector
Biopharma
Location
United States